Practical Tips for the Interprofessional Management of MASLD
This article provides practical guidance for managing Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). It emphasizes that lifestyle interventions, particularly weight loss and physical activity, remain the primary treatment strategies alongside patient education.
Why it matters
As MASLD prevalence grows, effective communication and multidisciplinary management are essential to prevent progression to advanced liver disease.
Author: *Anastasia Ntikoudi 1,2 1. WHO Athens Office Quality of Care and Patient Safety, Greece 2. University of West Attica, Aigaleo, Greece *Correspondence to [email protected]
Disclosure: The author has declared no conflicts of interest.
Keywords: Cardiometabolic disease, exercise, hepatocellular carcinoma, lifestyle intervention, MASLD, multidisciplinary care, pharmacological therapy, psychological health, weight loss.
Citation: EMJ Hepatol. 2026;14[1]:43-45. https://doi.org/10.33590/emjhepatol/41MM19B0
A key challenge for clinicians is communicating risk effectively to patients. Many individuals perceive MASLD as a relatively benign condition because they are often asymptomatic. 1 However, helping patients understand the broader cardiometabolic implications of MASLD may improve engagement with treatment and support long-term behavioural change. 1,2 Explaining that liver disease progression is only one component of the overall risk profile can help patients appreciate the importance of sustained lifestyle modification. 2,3
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in